Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2017-01-01 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VINCENNES (94300), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DU MIDI : revenue, balance sheet and financial ratios
SELAS PHARMACIE DU MIDI is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VINCENNES (94300),
this company of category PME
shows in 2023 a net income positive of 102 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DU MIDI (SIREN 824283998)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
102 226 €
112 610 €
163 502 €
136 420 €
74 186 €
105 185 €
95 435 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SELAS PHARMACIE DU MIDI generates positive net income of 102 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 95 k€ -> 102 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
102 226 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 196%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
195.5%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.049%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DU MIDI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
78.018
59.99
48.133
65.533
51.452
40.735
195.5
Financial autonomy
45.56
53.135
56.303
50.807
55.086
58.852
25.049
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
195.52023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+40 pts over 3 years
In 2023, the debt ratio of SELAS PHARMACIE DU MIDI (195.50) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
25.05%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average-38 pts over 3 years
In 2023, the financial autonomy of SELAS PHARMACIE DU MIDI (25.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 109.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
109.887
Liquidity indicators evolution SELAS PHARMACIE DU MIDI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
94.281
91.904
84.447
191.531
197.195
171.092
109.887
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
109.892023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch-32 pts over 3 years
In 2023, the liquidity ratio of SELAS PHARMACIE DU MIDI (109.89) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELAS PHARMACIE DU MIDI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELAS PHARMACIE DU MIDI is estimated at
1 206 213 €
(range 733 556€ - 1 695 665€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
733k€1206k€1695k€
1 206 213 €Range: 733 556€ - 1 695 665€
NAF 5 année 2023
Valuation method used
Net Income Multiple
102 226 €
×
11.8x
=1 206 213 €
Range: 733 556€ - 1 695 665€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DU MIDI with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DU MIDI
What is the revenue of SELAS PHARMACIE DU MIDI ?
The revenue of SELAS PHARMACIE DU MIDI is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DU MIDI profitable?
Yes, SELAS PHARMACIE DU MIDI generated a net profit of 102 k€ in 2023.
Where is the headquarters of SELAS PHARMACIE DU MIDI ?
The headquarters of SELAS PHARMACIE DU MIDI is located in VINCENNES (94300), in the department Val-de-Marne.
Where to find the tax return of SELAS PHARMACIE DU MIDI ?
The tax return of SELAS PHARMACIE DU MIDI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DU MIDI operate?
SELAS PHARMACIE DU MIDI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart